Sold before it exists: the company is already taking committed orders or reservations for output it cannot yet produce
The model's full reasoning — Q3 2018 call → NOWe need to answer YES or NO based on the transcript. The question asks: does management describe that counterparties have already committed to take output, product, capacity, or service that the company is not yet able to deliver? That is, buyers/partners have signed up, ordered, reserved, etc., for something the company hasn't finished building or doesn't yet have capability to supply. We need to find if management mentions any such commitments. Look for phrases like "orders", "commitments", "partnerships", "agreements", "pre-orders", etc., and whether the company is still building capability. In the transcript, Ilan discusses ICP, Perkin Elmer collaboration. He says: "The co-marketing agreement recently announced is the first step in building a strong ongoing relationship with Perkin Elmer." That's a co-marketing agreement, not a commitment to take output. He also says: "we estimate 2019 revenues between several hundreds to several million dollars resulting from the market penetration of ICP within current and future Perkin Elmer and Precipio customers" - that's an estimate, not a commitment. He mentions "several potential collaborations with other companies that we're working on" - that's prospective. For HemeScreen: "Since the launch of the test in our lab, only two weeks ago, we've already received numerous orders -- we've already run numerous orders received from physicians." That's actual orders for a test that is already launched and running in their lab. So they have the capability to deliver that test. The question is about commitments for something not yet able to deliver. HemeScreen is already in production in their lab, so that's not it. IV-Cell: "we learned then in fact commercialization was possible without this external academic validation. Interested parties -- partners that connected with us received samples of reagent and were able to test the IV-Cell technology in their own laboratory to see it works." That's testing, not commitments. Pathology services: they have a sales force, growing customer base, but that's existing services. The question specifically asks: "COUNTERPARTIES HAVE ALREADY COMMITTED TO TAKE OUTPUT, PRODUCT, CAPACITY, OR SERVICE THAT THE COMPANY IS NOT YET ABLE TO DELIVER" - meaning the company has sold something it hasn't built yet. In the transcript, there is no mention of such commitments.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
GOGO · Q1 2016 → YESThe question is: Does management describe that counterparties have already committed to take output, product, capacity, or service that the company is not yet able to deliver? YES Management describes real commitments (Delta >600, IAG 130+, Shareco 50, Air Canada wide-body fleet, total 2Ku awarded >1000) already made by counterparties. They also state the company is not yet able to deliver at scale ("begin the enviable task of installing the 1000 2Ku awarded aircraft", "we expect to install the majority of our awarded aircraft by the end of 2018", "STCs... will keep us on track to exceed our 75 2Ku installation target this year", "supply chain is there", "aggressive STC program...
SYM · Q3 2022 → YESThe question is: Does management describe that counterparties have already committed to take output that the company is not yet able to deliver? Like a backlog of things they haven't built yet. YES The transcript shows management describing a $11.3 billion contracted revenue backlog (more than doubled) with customers having "voted with their wallets," alongside 13 systems currently in deployment (plus 6 fully ramped) that will take roughly 18 months to acceptance.
BXP · Q1 2022 → YESThe question is about whether management describes counterparties that have already committed to take output that the company is not yet able to deliver, like pre-leased developments that aren't built...YES The transcript shows multiple instances where management describes counterparties having already signed leases for space in developments that have not yet been completed or even commenced construction.